Targeted IL-22 Improves Glucose Tolerance and Reduces Hepatic Steatosis and Hepatic Fibrosis in Murine Models of Diabetes and Liver Disease

被引：0
|
作者：
Prins, John B.
Sajiir, Haressh
Keshvari, Sahar
Wong, Kuan Yau
Lockett, Jack
McGuckin, Michael
Hasnain, Sumaira Z.
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-119-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
119-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Modulating intestinal neuroimmune VIPergic signaling attenuates the reduction in ILC3-derived IL-22 and hepatic steatosis in MASLD
    Nguyen, Henry H.
    Talbot, Jhimmy
    Li, Dayi
    Raghavan, Varsha
    Littman, Dan R.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (11)
  • [32] Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease
    Pathil, Anita
    Mueller, Jan
    Warth, Arne
    Chamulitrat, Walee
    Stremmel, Wolfgang
    HEPATOLOGY, 2012, 55 (05) : 1369 - 1378
  • [33] Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice
    Xu, AM
    Lam, MC
    Chan, KW
    Wang, Y
    Zhang, JL
    Hoo, RLC
    Xu, JY
    Chen, BY
    Chow, WS
    Tso, AWK
    Lam, KSL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (17) : 6086 - 6091
  • [34] α-Linolenic acid prevents hepatic steatosis and improves glucose tolerance in mice fed a high-fat diet
    Goncalves, Natalia Bonissi
    Bannitz, Rafael Ferraz
    Silva, Bruna Ramos
    Becari, Danielle Duran
    Poloni, Carolina
    Gomes, Patricia Moreira
    Foss, Milton Cesar
    Foss-Freitas, Maria Cristina
    CLINICS, 2018, 73
  • [35] Hepatic Fibrosis but Not Steatosis Is Associated with Diabetic Kidney Disease in Nonobese Patients with Type 2 Diabetes
    Seo, Da Hea
    Cho, Yongin
    Ahn, Seong Hee
    Hong, Seongbin
    Lee, Yong-Ho
    Choi, Youngju
    Huh, Byoung Wook
    Huh, Kap Bum
    Kim, So Hun
    DIABETES, 2020, 69
  • [36] Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease
    Galloway, Chad A.
    Lee, Hakjoo
    Brookes, Paul S.
    Yoon, Yisang
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2014, 307 (06): : G632 - G641
  • [37] Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
    Tran Thi Khanh Tuong
    Dang Khoa Tran
    Pham Quang Thien Phu
    Tong Nguyen Diem Hong
    Thien Chu Dinh
    Dinh Toi Chu
    DIAGNOSTICS, 2020, 10 (03)
  • [38] Risk Factors for Hepatic Steatosis in Cystic Fibrosis Are Distinct from Risk Factors for Cystic Fibrosis Liver Disease
    Ayoub, Fares
    Lascano, Jorge
    Morelli, Giuseppe
    HEPATOLOGY, 2017, 66 : 663A - 664A
  • [39] Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease
    Abrams, GA
    Kunde, SS
    Lazenby, AJ
    Clements, RH
    HEPATOLOGY, 2004, 40 (02) : 475 - 483
  • [40] Reply to: "Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in nonalcoholic fatty liver disease"
    Styczynski, Grzegorz
    Kalinowski, Piotr
    Michalowski, Lukasz
    Paluszkiewicz, Rafal
    Ziarkiewicz-Wroblewska, Bogna
    Zieniewicz, Krzysztof
    Tataj, Emanuel
    Szmigielski, Cezary
    Jedrusik, Piotr
    ATHEROSCLEROSIS, 2019, 290 : 224 - 225
12345